We speculate that broader use of this strategy will be useful to move us into the realm of phenotype-targeted therapy for a broad range of human conditions.
Yet, it is unclear how to optimize use of this strategy.
The use of this strategy simplifies the implementation of the modeling system.
If killing terrorist leaders does little on its own to defeat terrorist groups, then why do countries like the United States make such frequent use of this strategy?
The use of this strategy may help correct even slight weight regain and contribute to long-term weight stability.
Thus rejuvenation of the thymus alongside HSCT may potentiate the use of this strategy in the clinic.
Despite use of this strategy, the postthrombotic syndrome (PTS) develops frequently, causes substantial patient disability, and impairs quality of life.
Thanks to use of this strategy the transient performance of the system, such as overshoot and speed of response, becomes greatly adjustable.
The use of this strategy will probably lead to an intracellular, intercellular and systemic amplification of the specific virus-targeted interfering activities.
The use of this strategy by interviewees illustrates how power struggles occur in government decision-making processes which involve both medical expertise and patients' accounts.
However, aldehydes are metabolically unstable, which precludes the use of this strategy for compounds to be tested in animal models or in human clinical studies.
